High Sensitivity Troponin 0/1 Hour Rule Out Rule In Algorithm Tool

Clinical calculation support · Verify results before clinical use

Clinical assessment

Enter the 0-hour and 1-hour hs-cTnT concentrations in ng/L. Use only with the specified assay and appropriate clinical assessment.

0 / 1 h Serial hs-cTnT

Sample obtained at 0 hours, as soon as possible after presentation.

Sample obtained at the validated 1-hour time point.

Awaiting
input
Algorithm classification

Enter both measurements

The pathway will be displayed after valid values are entered.

Clinical interpretation

This calculator supports, but does not replace, clinical assessment, ECG interpretation, symptom timing, and local ACS pathways.

Absolute delta is the absolute difference between the 1-hour and baseline hs-cTnT values.

How to interpret the pathway

This implementation uses the ESC 0-hour/1-hour thresholds for Roche Elecsys high-sensitivity cardiac troponin T (hs-cTnT). These cutoffs must not be applied to hs-cTnI assays or other hs-cTnT platforms without assay-specific validation.

PathwayCriteria used by this toolMeaning
Rule-outBaseline <12 ng/L and absolute 1-hour delta <3 ng/LLow likelihood of NSTEMI within the algorithm; integrate with symptoms and ECG.
Rule-inBaseline ≥52 ng/L or absolute 1-hour delta ≥5 ng/LHigh likelihood of NSTEMI or myocardial injury; prompt clinical evaluation is required.
ObserveNeither rule-out nor rule-in criteria are metIndeterminate zone; reassess clinically and obtain further testing as indicated.

Important application notes

  • Use the algorithm in patients with suspected ACS without an indication for immediate invasive management.
  • Rule-in indicates a high probability, not a definitive diagnosis of type 1 myocardial infarction. Troponin elevation can occur with other causes of myocardial injury.
  • Patients in the observe zone generally require further hs-cTn measurement (often at 3 hours), ECG reassessment, and clinical review according to the local pathway.
  • Ongoing or recurrent chest pain, ischemic ECG changes, hemodynamic instability, or high clinical suspicion require action regardless of the calculated category.

References

Byrne RA, Rossello X, Coughlan JJ, et al. 2023 ESC Guidelines for the management of acute coronary syndromes. European Heart Journal. 2023;44(38):3720–3826. The guideline specifies assay-dependent 0 h/1 h and 0 h/2 h pathways and requires integration with clinical assessment and a 12-lead ECG. doi:10.1093/eurheartj/ehad191
Collet JP, Thiele H, Barbato E, et al. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. European Heart Journal. 2021;42(14):1289–1367. Includes the Roche Elecsys hs-cTnT 0 h/1 h thresholds: low <12 ng/L, no significant 1-hour delta <3 ng/L, high ≥52 ng/L, and 1-hour delta ≥5 ng/L. doi:10.1093/eurheartj/ehaa575
Reichlin T, Schindler C, Drexler B, et al. One-hour rule-out and rule-in of acute myocardial infarction using high-sensitivity cardiac troponin T. Archives of Internal Medicine. 2012;172(16):1211–1218. doi:10.1001/archinternmed.2012.3698
Clinical disclaimer: This tool is an aid to clinical decision-making, not a standalone diagnostic test. Its thresholds are assay-specific and intended for the Roche Elecsys hs-cTnT 0 h/1 h algorithm. A rule-out result does not by itself establish suitability for discharge, and a rule-in result does not alone confirm myocardial infarction. Interpret results with symptom onset and course, serial ECGs, clinical findings, and local protocols.